erlotinib has been researched along with bohemine in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (bohemine) | Trials (bohemine) | Recent Studies (post-2010) (bohemine) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 30 | 0 | 7 |
| Protein | Taxonomy | erlotinib (IC50) | bohemine (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 1.1 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 1.8 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 1.1 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 1.65 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 1.65 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.3667 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 1.1 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 1.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for erlotinib and bohemine
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |